Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis-Reference-Cited by-同舟云学术

Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis

Published:2010-09 Issue:6 Volume:13 Page:853-856
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Boersma Cornelis,Broere Adriaan,Postma Maarten J.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference11 articles.

1. Public health economics of vaccines in the Netherlands: methodological issues and applications;Postma;J Public Health,2008

2. NICE and the challenge of cancer drugs;Raftery;BMJ,2009

3. Interpretation of cost-effectiveness analyses;Owens;J Gen Intern Med,1998

4. Using pharmacoeconomics for policy-making: is rational decision-making enhanced by cost-effectiveness analysis?;Bos;Exp Rev Pharmacoeconom Res,2004

5. Rechtvaardige En Duurzame Zorg (in Dutch);Raad voor Volksgezondheid & Zorg (RVZ),2007

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on the direct approach to elicit the demand-side cost-effectiveness threshold: Implications for low- and middle-income countries;PLOS ONE;2024-02-08

2. An enhanced multilevel secure data dissemination approximate solution for future networks;PLOS ONE;2024-02-08

3. Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom;The Journal of Infectious Diseases;2021-09-15

4. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program;Value in Health;2021-01

5. Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands;The European Journal of Health Economics;2020-10-16